Relmada Therapeutics (RLMD) Invested Capital (2014 - 2020)
Powered by 
Analysis
Relmada Therapeutics (RLMD) Invested Capital (2014 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 105.58 Mn |
| Sep 30, 2020 | 122.21 Mn |
| Jun 30, 2020 | 132.23 Mn |
| Mar 31, 2020 | 113.16 Mn |
| Dec 31, 2019 | 115.90 Mn |
| Sep 30, 2019 | 6.49 Mn |
| Jun 30, 2019 | 8.34 Mn |
| Mar 31, 2019 | 531,467.00 |
| Dec 31, 2018 | 1.66 Mn |
| Sep 30, 2018 | -974,819.00 |
| Jun 30, 2018 | 1.34 Mn |
| Mar 31, 2018 | 3.22 Mn |
| Dec 31, 2017 | 5.68 Mn |
| Sep 30, 2017 | 4.66 Mn |
| Jun 30, 2017 | 2.01 Mn |
| Mar 31, 2017 | 3.11 Mn |
| Dec 31, 2016 | 5.31 Mn |
| Sep 30, 2016 | 6.71 Mn |
| Jun 30, 2016 | 8.21 Mn |
| Mar 31, 2016 | 10.82 Mn |